A pair of Caltech research teams have created an entirely new kind of drug-delivery system, one that they say may finally give doctors the ability to treat cancer in a more targeted way. The system employs drugs that are activated by ultrasound—and only right where they are needed in the body.
The system was developed in the labs of Maxwell Robb, assistant professor of chemistry, and Mikhail Shapiro, Max Delbrück Professor of Chemical Engineering and Medical Engineering and Howard Hughes Medical Institute investigator. In a paper appearing in the journal Proceedings of the National Academy of Sciences, the researchers show how they combined elements from each of their specialties to create the platform. [Caltech story]